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Abstract 23 
The order Nidovirales comprises four virus families: Arteriviridae, Coronaviridae 24 
(divided into two subfamilies Coronavirinae and Torovirinae), Roniviridae and recently 25 
recognized Mesoniviridae. RNA cap formation and methylation have been well studied 26 
for coronaviruses, focusing on identification and characterization of two cap 27 
methyltransferases (MTases), guanine-N7-MTase and ribose-2′-O-MTase. Although 28 
bioinformatic analyses suggest that the MTases may also be encoded by other large-29 
sized nidoviruses such as toroviruses and roniviruses, no experimental evidences have 30 
been provided. In this study, we showed that a ronivirus, gill-associated nidovirus, 31 
encodes the 2′-O-MTase activity but we could not detect the activity in the homologous 32 
protein of a torovirus, equine torovirus, which is more closely related to coronaviruses. 33 
Roniviral 2′-O-MTase possesses similar and unique features in comparison with that of 34 
coronaviruses. It harbors a catalytic K-D-K-E tetrad and possibly a Rossman-like fold 35 
conserved among 2′-O-MTases and can only target the N7-methylated cap structure of 36 
adenylate-primed RNA substrates. However, roniviral 2′-O-MTase does not require a 37 
protein cofactor for activity stimulation as coronaviruses and shows distinct properties 38 
in several biochemical parameters such as reaction temperature and pH. Furthermore, 39 
the ronivirus 2′-O-MTase can be targeted by MTase inhibitors. These results extend 40 
current understanding on the RNA cap formation and methylation beyond 41 
coronaviruses in the order Nidovirales. 42 
 43 
  44 
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Introduction 45 
The 5′-terminal cap structure, an N7-methylguanosine linked to the first transcribed 46 
nucleotide via a 5′-5′ triphosphate bridge, exists widely in many viral and eukaryotic 47 
cellular mRNAs, and plays a critical role in RNA stability and protein translation 48 
(Bouvet et al., 2012; Furuichi & Shatkin, 2000; Ghosh & Lima, 2010). The cap-0 49 
structure m7GpppN is formed by the sequential reactions catalyzed by RNA 50 
triphosphatase, guanylyltransferase and guanine-N7-methyltransferase (N7-MTase) 51 
(Bouvet et al., 2012; Decroly et al., 2012; Ghosh & Lima, 2010). In higher eukaryotes 52 
and most viruses, the cap-0 structure is further methylated at the ribose 2′-O position 53 
by ribose 2′-O methyltransferase (2′-O MTase) to form a cap-1 structure (m7GpppNm2) 54 
(Chen & Guo, 2016; Chen et al., 2011; Decroly et al., 2012). Recently, it has been 55 
reported that 2′-O methylation of viral mRNA cap is important for RNA viruses to evade 56 
host innate immune responses (Daffis et al., 2010; Zust et al., 2011). 57 
The order Nidovirales is composed of the most complex positive-sense single-stranded 58 
RNA (ssRNA+) viruses with human and animal hosts, including the highly pathogenic 59 
severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) and Middle East 60 
respiratory syndrome coronavirus (MERS-CoV). It consists of four virus families, 61 
including Arteriviridae (12.7-15.7-kb genomes; known as ′′small-sized nidoviruses′′), 62 
Coronaviridae, Roniviridae and the recently recognized Mesoniviridae (26.3-31.7 kb; 63 
the latter three families being referred to as ′′large-sized nidoviruses′′) (Lauber et al., 64 
2012). The Coronaviridae is further classified into two subfamilies, Coronavirinae (for 65 
coronaviruses) and Torovirinae (for toroviruses). The Nidoviruses are evolutionarily 66 
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related and share several common features, for example, synthesis of a set of 67 
subgenomic RNAs in the manner of discontinuous transcription and adoption of various 68 
RNA processing enzymes in genome replication (Gorbalenya et al., 2006; Hussain et 69 
al, 2005). Recently, the cap formation and methylation have been extensively studied 70 
for coronaviruses, focusing on two virally encoded S-adenosyl-L-methionine (SAM or 71 
AdoMet)-dependent methyltransferases: N7-MTase and 2′-O MTase. Our previous 72 
work has demonstrated that coronavirus non-structural protein (nsp) 14 functions as an 73 
N7-MTase (Chen et al., 2009; Chen et al., 2013) while other studies have shown that 74 
coronaviral nsp16 acts as a 2′-O-MTase with the help of the viral cofactor nsp10 75 
(Bouvet et al., 2010; Chen et al., 2011; Decroly et al., 2011; Decroly et al., 2008; Wang 76 
et al., 2015). However, there is no experimental evidence to show that any other 77 
nidoviruses (excepting coronaviruses) possess a functional methyltransferase.  78 
According to bioinformatic analysis, all nidoviruses except arteriviruses encode a 2′-O- 79 
MTase domain at the C-terminal end of the large open reading frame 1b whereas all 80 
large-sized nidoviruses excepting toroviruses possess an N7-MTase domain following 81 
the exoribonuclease domain (Gorbalenya et al., 2006; Nga et al., 2011; Snijder et al., 82 
2003). We have attempted to address whether the large-sized non-coronaviral 83 
nidoviruses also encode methyltransferases involved in viral RNA cap methylation by 84 
utilizing the genetic and biochemical methodologies established in our laboratory 85 
(Chen et al., 2009; Chen et al., 2011), but we failed to detect any N7-MTase activity of 86 
the proteins encoded by roniviruses, mesoniviruses and toroviruses (unpublished 87 
results). In this study, we show that the MTase domain of a ronivirus (arbitrarily named 88 
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as "nsp16" by the analogy with the location and function of coronaviral nsp16), but not 89 
torovirus MTase domain (also named as nsp16), possesses the 2′-O-MTase activity. We 90 
further demonstrate that ronivirus nsp16 alone can efficiently execute its MTase activity, 91 
which is in contrast with coronaviral nsp16 that requires virus-encoded nsp10 as a 92 
cofactor for its full function. These results extend the understanding of nidovirus RNA 93 
capping and methylation and provide an evolutionary and functional link between 94 
roniviruses and coronaviruses. 95 
 96 
Materials and methods 97 
Radioactive reagents. S-adenosyl [methyl-3H] methionine (67.3 Ci/mmol, 0.5 µCi/µl) 98 
and [α-32P]-labeled guanosine 5′-triphosphate (3000Ci/mmol, 10mCi/ml) were 99 
purchased from PerkinElmer. 100 
Cloning, expression and purification of the related proteins. The genomic cDNA of 101 
shrimp gill-associated nidovirus (GAV), a type species of Roniviridae, was kindly 102 
provided by Dr. J.A. Cowley and was used as the template to construct the expression 103 
constructs. Two pairs of PCR primers were used to amplify the gene fragments of GAV: 104 
5′-CGGGATCCCTCAGTTACTCAGGCACCGC-3′ (sense) and 5′-105 
CCCTCGAGCTCGTGCTTGACTGGGATGG-3′ (antisense) for GAV nsp10, and 5′-106 
CGGGATCCCTCTACCACGTCGCTCCTAC-3′ (sense) and 5′-107 
CCCTCGAGAAATTTGATGAATCTGGGAG-3′ (antisense) for GAV nsp16, which 108 
correspond to the nucleotides 11703-12212 and 19403-20089 of the GAV genome 109 
(GI:166851932), respectively. These PCR products were cloned into the Escherichia 110 
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coli expression vector pGEX-6p-1, resulting in the expression constructs pGEX-6p-1-111 
GAV nsp10 and pGEX-6p-1-GAV nsp16. The mutant plasmids of GAV nsp16 were 112 
generated by one-step PCR with mutagenic primers. 113 
E. coli BL21 (DE3), transformed with pGEX-6p-1-GAV nsp10 or nsp16, was grown in 114 
Luria broth (LB) medium containing ampicillin at 37°C. When the OD600nm value of 115 
the culture reached 0.6, isopropyl-β-D-thiogalactopyranoside (IPTG) was added to a 116 
final concentration of 0.4 mM, and induced at 16°C for 16 hours. Bacterial cells were 117 
harvested by centrifugation and lysed by sonication. The GST-tagged fusion proteins 118 
were purified from the cell lysate by affinity chromatography using Glutathione Resin 119 
(GenScript) according to the manufacturer's instructions. GAV nsp10 (pp1a residues 120 
3879-4048, 170 aa) fused with GST-tag is about 45 kD and was confirmed by SDS-121 
PAGE. GAV nsp16 (pp1ab residues 6446-6673, 228 aa) fused with GST-tag is about 52 122 
kD. 123 
The genes of equine torovirus (EToV) were obtained by PCR reactions with the 124 
template of EToV genome cDNA (GI:190360102) kindly provided by Eric J. Snijder. 125 
We performed the bioinformatic analysis to predict the proteinase cleavage sites and 126 
arbitrarily named the most C-terminal cleavage product of pp1a as EToV nsp10 and 127 
that of pp1b as EToV nsp16 (the predicted 2'-MTase domain).   The following primers 128 
were used to amplify the gene fragments: sense 5′-129 
CGGGATCCGGTGTTAGATTGGGAGGTGT-3′ and antisense 5′-130 
CCCTCGAGCTGAGGCTTAAAAACTGGA-3′ for EToV nsp10 (nt 13560-14018 of 131 
the genome), and 5′-CGGGATCCAAGGATTTTGTAAGGTCGTA-3′ (sense) and 5′-132 
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CCCTCGAGATGTTCCATTTGGCACAAC-3′ (antisense) for EToV nsp16 (20597-133 
21391). The PCR fragments were cloned into E. coli expression vectors pET30a and 134 
pGEX-6p-1 respectively, generating the plasmids of pET30a-EToV nsp10 and pGEX-135 
6p-1-EToV nsp16. 136 
GST fusion protein of EToV nsp16 (pp1ab residues 6593-6857, 265aa) was expressed 137 
and purified similarly to GAV nsp16, and the fusion protein size was 57 kD. The 138 
pET30a-EToV nsp10 was transformed into E. coli BL21(DE3), and the cells were 139 
grown in LB medium containing kanamycin at 37°C. When the OD600nm value of the 140 
culture reached 0.6, isopropyl-β-D-thiogalactopyranoside (IPTG) was added to a final 141 
concentration of 0.4 mM, and the culture was grown for additional 16 hours at 16°C. 142 
Bacterial cells were harvested by centrifugation and lysed by sonication. The 6-143 
Histidine-tagged protein was purified from the cell lysate by affinity chromatography 144 
using Ni-NTA according to the manufacturer's instructions (Qiagen). EToV nsp10 (pp1a 145 
residues 4247-4399, 153aa) was 17 kD in size. The predicted sizes of these two proteins 146 
were in accordance with their sizes in SDS-PAGE analysis.  147 
SARS-CoV nsp10 and nsp16 were expressed and purified as described in our previous 148 
work (Chen et al., 2011). 149 
Preparation of RNA substrates. GAV 68-nt 5′-UTR was transcribed in vitro using the 150 
PCR products as a template which was amplified from GAV cDNA (primers as follows, 151 
5′-CAGTAATACGACTCACTATTACGTTACGTTCCACGTAC-3′ and 5′-152 
GGTCGGAAACGCTGGAAAAC-3′). Since GAV genome possesses an adenine at the 153 
5'-proximal first nucleotide position, we used a bacteriophage T7 Φ2.5 promoter to 154 
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promote synthesis of RNA which initiated with an adenine. The MEGAscript Kit (Life 155 
Technologies) was used to transcribe RNA in vitro with 100 ng PCR template in a 20-156 
μl mixture. The reaction mixture was mixed thoroughly and incubated for 16 h at 37°C. 157 
After the reaction, 2 units of TURBO DNase was added, followed by further incubation 158 
for 15 min at 37°C. For purification of RNA, the transcription reaction was extracted 159 
with phenol/chloroform/isoamyl alcohol, precipitated with 75% ethanol which contains 160 
sodium acetate, resuspended in RNA-free water (TIANGEN), and quantitated by 161 
Nanodrop 2000c (Thermo Scientific). Nonviral RNAs pppACn, pppUC20, pppGC20, and 162 
pppCC20 were transcribed and purified as described previously (Chen et al., 2011).  163 
Capped RNAs (GpppRNA and 7MeGpppRNA) were produced using Vaccinia Capping 164 
System (New England Biolabs), purified through Sephadex G-25 quick spin columns 165 
(Roche), extracted with phenol/chloroform/isoamyl alcohol and precipitated with 166 
ethanol.32P-labeled RNA substrates (G*pppRNA and 7MeG*pppRNA) used for thin 167 
layer chromatography (TLC) were synthesized as described previously (Chen et al., 168 
2009). 169 
Biochemical assay for methyltransferase activity. The 32P-labeled 2′-O-MTase assay 170 
was performed in 8.5-μL reaction system (containing 50 mM Tris-HCl [pH 8.0], 2 mM 171 
dithiothreitol [DTT], 2 mM MgCl2, 10 units RNase inhibitor, 2×103 cpm of 7MeG 172 
*pppA-RNA, 0.2 mM SAM, and 0.5 μg of purified proteins or mutant proteins) at 20°C 173 
for 1 h. Control G*pppA-RNA and 7MeG*pppA-RNA were prepared by using the 174 
vaccinia virus protein D1-D12, which has the activity of both GTase and N-7-MTase  175 
by incubating at 37°C for 1 h and purified as described previously (Chen et al., 2011). 176 
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Control 7MeG*pppAm-RNA was produced by incubation of 7MeG*pppA-RNA with the 177 
vaccinia virus 2′-O-methyltransferase VP39 (Epicentre) at 37°C. The capped RNAs 178 
labeled by radioisotope were digested by nuclease P1 (US Biological) to release cap 179 
structures, then spotted onto polyethyleneimine cellulose-F plates (Merck) for TLC 180 
analysis, and developed in 0.65 M LiCl. The extent of 32P-labeled cap was determined 181 
by scanning the chromatogram with a Phosphorlmager as described previously (Chen 182 
et al., 2009; Chen et al., 2011). 183 
The 3H-methyl incorporation MTase activity assays were performed in 20-µL reaction 184 
system (containing 50 mM Tris-HCl [pH 8.0], 2 mM DTT, 2 mM MgCl2, 40 units of 185 
RNase inhibitor, 0.01 mM SAM, 0.5 µCi of S-adenosyl [methyl-3H] methionine [67.3 186 
Ci/mmol, 0.5 µCi/µl], 1 µg proteins, and 3 µg of 7MeGpppRNA substrates) at 37°C for 187 
1 h. 3H-labeled products were isolated in DEAE-Sephadex A-50 columns and 188 
quantitated by liquid scintillation (PerkinElmer) as described previously (Ahola et al., 189 
1997; Chen et al., 2011). 190 
Multiple sequence alignment and homology modeling 191 
The multiple sequence alignment of the nsp16 protein sequence from different 192 
Nidovirales species was performed by using Clustalx, and then the result was imported 193 
into ESPript 3.0 together with the three-dimensional structure of SARS nsp16/nsp10 194 
(PDB: 3R24) to assign the secondary structure. The 3D structure of GAV nsp16 was 195 
generated on the template structure SARS-CoV nsp16 (PDB 3R24, chain A). The 196 
multiple sequence alignment was done by Clustalx, and then uploaded to SWISS-197 
MODEL for structural modeling, which was further analyzed by PyMol. 198 
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 199 
Results 200 
Ronivirus nsp16 possesses SAM-dependent 2′-O-MTase activity in the absence of 201 
another protein co-factor  202 
Bioinformatic analysis revealed that all large-sized nidoviruses encode a putative 2′-O-203 
MTase domain located at the most C-terminal end of the replicase pp1ab polyprotein 204 
(Gorbalenya et al., 2006). As coronaviral nsp16 with nsp10 as an essential cofactor has 205 
been demonstrated as a functional 2′-O-MTase (Bouvet et al., 2010; Chen et al., 2011; 206 
Decroly et al., 2011; Wang et al., 2015), we further characterized the homologous 207 
proteins of torovirus and ronivirus for 2′-O-MTase activity. For this purpose, we 208 
selected two representative viruses, one being equine torovirus (EtoV) (Smits et al., 209 
2006) that belongs to the subfamily of Coronaviridae and is more closely related to 210 
coronaviruses, and the other being gill-associated okavirus (GAV) (Cowley et al., 2000; 211 
Cowley & Walker, 2002) that belongs to the Roniviridae and is distantly related to 212 
coronaviruses. As the proteinase cleavage sites are not completely established for the 213 
large polyprotein 1ab of these two viruses, their protein counterparts for coronavirus 214 
nsp16 and nsp10 are arbitrarily named as EToV or GAV "nsp16" and "nsp10", 215 
respectively, in analogy to CoV protein nomenclature. The well characterized 2′-O-216 
MTases SARS-CoV nsp10/nsp16 and vaccinia VP39 were used as controls (Chen et al., 217 
2011; Wang et al., 2015). The locations of the predicted proteinase cleavage sites and 218 
nsp10/16 in the polyprotein pp1ab are indicated in Figure 1A. 219 
As shown in Fig. 1B, the recombinant proteins of nsp10 and nsp16 of EToV, GAV and 220 
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SARS-CoV were expressed in E. coli cells and purified to more than 95% homogeneity 221 
by affinity chromatography. 222 
To test the 2′-O-MTase activity possibly possessed by the viral proteins, we first 223 
conducted 2′-O-MTase activity assays in vitro on a 21-nt RNA substrate (the cap-0 224 
7MeGpppAC20) which was capped and methylated at N7 position of the cap. Transfer of 225 
3H-labeled methyl group from SAM to cap-0 RNA substrates resulted in cap-1 RNA 226 
(7MeGpppAmC20) and could be measured quantitatively by liquid scintillation detection. 227 
As the GAV host shrimps (Penaeus monodon) keep a low body temperature in nature, 228 
all the assays with GAV proteins were performed at 20°C while all other assays were at 229 
37°C. As shown in Figure 1C, GAV nsp16, either in the presence or absence of GAV 230 
nsp10, showed remarkable 2′-O-MTase activity to the similar extent as vaccinia VP39 231 
and SARS-CoV nsp10/nsp16, whereas EToV nsp16 or its mixture with nsp10 did not 232 
display 2′-O-MTase activity, similarly to the negative control (SARS-CoV nsp10 alone). 233 
These results indicate that GAV nsp16 alone possesses the 2′-O-MTase activity, which 234 
is different from coronavirus nsp16 that requires nsp10 as a stimulating co-factor. 235 
We further tested the 2′-O-MTase activity of GAV nsp16 with the capped viral RNA 236 
substrates (7MeG*pppA-RNA, where the asterisk-marked phosphate was 32P labeled) 237 
containing the 5′-terminal 68nt of GAV genome. GAV nsp16 was incubated with 238 
7MeG*pppA-RNA in the presence of 0.2 mM SAM. After incubation, the RNA was 239 
digested with nuclease P1 to release the cap structure and analyzed on TLC plates 240 
(Fig.2A, lane 1). The radio-labeled cap analogs G*pppA, 7MeG*pppA and7MeG*pppAm, 241 
generated by vaccinia D1/D12, VP39 and P1 treatment, were used as controls (Fig.2A, 242 
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lanes 2, 3, 4). When the 2′-O position of substrate′s first nucleotide was methylated, the 243 
released cap structure was 7MeG*pppAm, and the 2′-O methylated and unmethylated cap 244 
structures could be readily separated on TLC plates. As shown in Figure 2A, the 2′-O 245 
methylated cap (7MeG*pppAm) (lane 4) generated by VP39 migrated a shorter distance 246 
than 2′-O unmethylated cap-0 structure (7MeG*pppA) (lane 3), which were used as the 247 
position indicators for the reaction products of GAV nsp16. The cap structure released 248 
from 7MeG*pppA-RNA treated with GAV nsp16 corresponded with7MeG*pppAm, 249 
further confirming that GAV nsp16 functions as a methyltransferase that adds a methyl 250 
group at the ribose 2′-O position.  251 
GAV nsp16 specifically methylates ATP-initiated N7-methylated cap-0 structure 252 
of RNA substrates 253 
Next, we explored whether GAV nsp16 could methylate capped RNA GpppACn that 254 
was not methylated at N7 position. As shown in Figure 2B, when uncapped RNA 255 
oligonucleotide pppAC20 and capped RNA oligonucleotide GpppAC20 (which is not 256 
methylated at the N7 position) were used as substrates, 3H-methyl groups could not be 257 
incorporated neither by GAV nsp16 nor by SARS nsp16/nsp10. In contrast, when RNA 258 
oligonucleotides containing N7-methylated cap-0 structure 7MeGpppAC20 (black bars in 259 
Fig. 2B) were used as substrates, there was strong signal for incorporated 3H-methyl 260 
groups both by GAV nsp16 and SARS nsp16/nsp10. These data suggest that GAV nsp16 261 
can only methylate cap-0 structure of RNA substrates (7MeGpppA-RNA), similarly to 262 
coronavirus 2′-O-MTase.  263 
It had been reported that vaccinia virus VP39 was a 2′-O-MTase which modifies 5′-264 
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capped mRNA in sequence-nonspecific manner (Hodel et al., 1998). However, in our 265 
previous study, we found that SARS-CoV nsp16 MTase methylated 7MeGpppA-RNA 266 
but not 7MeGpppG-RNA (Chen et al., 2011), indicating that SARS-CoV nsp16 is a 267 
sequence-dependent 2′-O methyltransferase for ATP-initiated mRNA. In a similar way, 268 
we studied the substrate specificity of GAV nsp16. A variety of capped RNA 269 
oligonucleotides (initiated with different nucleotides followed by 20 cytidines, 270 
(7MeGpppAC20, 
7MeGpppCC20,
 7MeGpppUC20, and 
7MeGpppGC20) and the cap analogue 271 
(7MeGpppA) were treated with purified GAV nsp16 in the presence of 3H-labeled SAM, 272 
purified and detected by liquid scintillation. As shown in Figure 2C, GAV nsp16 had 273 
robust activity on substrate 7MeGpppAC20 but no detectable activity on 
7MeGpppUC20 274 
and7MeGpppGC20 (Fig. 2C). Of note, GAV nsp16 showed a marginal activity on the 275 
substrate 7MeGpppCC20. These results indicate that GAV nsp16 2′-O-MTase has a 276 
preference to 7MeGpppA-initiated RNA, similarly to SARS-CoV nsp10/nsp16. 277 
Coincidentally, the very 5′-terminal nucleotide of GAV genome is adenylate, consistent 278 
with our observation.  279 
There was no activity of GAV nsp16 when the cap analogue 7MeGpppA was used as 280 
substrate (Fig. 2C), suggesting that the length of RNA substrate is a determinant for 281 
GAV nsp16 2′-O-MTase activity. We next characterized the correlation between MTase 282 
activity and RNA substrate length. RNA substrates of different length 7MeGpppACn (n=0 283 
to 10, 20) were obtained as described (see Materials and methods), and were treated 284 
with the equal amount of purified GAV nsp16. As shown in Figure 2D, there was no 285 
detectable 2′-O-MTase activity when the RNA substrates possessed less than 5 286 
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nucleotides (n=0 to 4). It showed a marginal activity when the RNA length reached 6 287 
nucleotides (n=5), and the activity increased gradually with the increase of RNA 288 
substrate length (n = 5-8). The activity of GAV nsp16 reached a plateau when RNA 289 
exceeded 9 nucleotides (n>8). These results imply that GAV nsp16 requires a certain 290 
length of RNA substrate for full activity. 291 
Biochemical parameters of GAV nsp16activity 292 
As the natural hosts for roniviruses are invertebrates, we further characterize the 293 
biochemical parameters and optimal reaction conditions for GAV nsp16 in vitro. First, 294 
the optimal temperature of the GAV nsp16 methyltransferase reaction was determined. 295 
Since the GAV natural host shrimps live in low temperature or temperature-varying 296 
environments, a series of temperatures were (from 10°C to 37°C) tested. As shown in 297 
Figure 3A, GAV nsp16 activity adopted typical bell curve of the temperature, with an 298 
optimal activity on 20°C, indicating that the GAV enzyme had higher activity at a lower 299 
temperature that is similar to its natural ambient temperature. In contrast, the 2′-O-300 
MTase of coronaviruses that infect mammalian hosts adopt a higher temperature for 301 
optimal enzymatic activity. 302 
We next tested the influence of pH on GAV nsp16 activity. The pH value of the buffer 303 
was adjusted from pH 6.0 to pH 11.0 in the assays, and the activity curve profile of 304 
GAV nsp16 at different pH values also fitted into a bell shape with a similar pattern to 305 
that of temperature changes (Fig. 3B). The GAV 2′-O-MTase had an optimal activity at 306 
pH 8.0, which is different from that of coronaviruses that has an optimal pH value at 307 
7.5 (Decroly et al., 2008). 308 
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We also investigated the effect of divalent ions on GAV nsp16 at the optimal 309 
temperature and pH, since it has been reported that divalent ions can stimulate the 310 
methyltransferase activity of several 2′-O-MTases (Decroly et al., 2008; Jeffery & Roth, 311 
1987). Mn2+, Mg2+ and Zn2+ were tested in our experiment system. Surprisingly, none 312 
of these divalent ions could stimulate the activity of GAV nsp16. On the contrary, high 313 
concentration of Mg2+ even suppressed the activity of GAV nsp16 remarkably (Fig. 3C). 314 
Moreover, we also determined the influence of Na+ on GAV nsp16, as some 2'-O-315 
MTases could only tolerate very low concentration of Na+ (Selisko et al., 2010). 316 
Interestingly, GAV nsp16 was not inhibited by a concentration of Na+ as high as 20 mM, 317 
which is different from Dengue virus NS5MTaseDV 2′-O-MTase (Selisko et al., 2010) 318 
and vaccinia virus VP39 (Barbosa & Moss, 1978). This observation is consistent with 319 
the fact that the natural hosts for GAV can live in a high salinity environment. 320 
The conserved K-D-K-E catalytic tetrad of 2′-O-MTase is required for the activity 321 
of GAV nsp16 2′-O-MTase 322 
The group of 2′-O-methyltransferases contains a conserved K-D-K-E catalytic tetrad, 323 
which performs a vital function for RNA 2′-O-MTase (Decroly et al., 2008; Egloff et 324 
al., 2002; Feder et al., 2003). To identify the K-D-K-E catalytic tetrad of GAV nsp16, 325 
we made a comparative analysis of GAV nsp16 with coronavirus nsp16. The multiple 326 
sequence alignment is shown in Figure 4A. In SARS-CoV, the conserved K-D-K-E 327 
residues of coronavirus nsp16 had been predicted (Lys-46, Asp-130, Lys-170 and Glu-328 
203) and confirmed by crystal structure analysis (Chen et al., 2011; Decroly et al., 2011). 329 
The amino acids marked with black asterisk were K-D-K-E tetrad predicted for GAV 330 
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nsp16 (Lys-39, Asp-114, Lys-144 and Glu-178), which are completely conserved in the 331 
2′-O-methyltransferases of the nidoviruses. We next generated a structural model of 332 
GAV nsp16 (Fig. 4B) by homology-based modeling with SARS-CoV nsp16 as the 333 
template (Fig. 4C).  As shown in the schematic diagrams of the structural topology 334 
(Fig. 4D), GAV nsp16 and SARS-CoV nsp16 share similar global structure with a 335 
parallel arrayed β-strands surrounded by a number of α-helices and loops. The K-D-K-336 
E tetrad residues predicted in GAV nsp16 were located in an α-helix and three parallel 337 
arrayed β-strands at similar positions to that of SARS-CoV nsp16. However, the 338 
structural model shows that GAV nsp16 possesses a six-stranded β-sheet instead of a 339 
seven-stranded β-sheet that exists in many known 2′-O-methyltransferases (Chen et al., 340 
2011; Martin & McMillan, 2002).  The missing β-strand of GAV nsp16 corresponds 341 
to the β-strand 3 (β3) of SARS-CoV nsp16 (Fig. 4A and 4D). Such structural 342 
discrepancy needs to be confirmed by the crystal structure analysis of GAV nsp16 in 343 
the future work. 344 
To experimentally confirm the K-D-K-E catalytic tetrad of GAV nsp16, the four 345 
residues (K39, D114, K144, and E178) were mutated to alanine or other amino acid 346 
residues with similar chemical property. In 3H-methyl incorporation MTase activity 347 
assays, we found that the wild type of GAV nsp16 possessed about 50% of the activity 348 
of the SARS nsp10/16 which was used as a positive control when tested at their 349 
respective optimal conditions (Fig. 5A and 5B). When any of the four residues was 350 
mutated to alanine, the 2′-O-MTase activity was completely abolished (Fig. 5A and 5B). 351 
When the residues were mutated to the amino acid residues with similar chemical 352 
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properties, GAV nsp16 activity was largely disrupted but still retained a trace amount 353 
of 2′-O-MTase activity (Fig. 5A and 5B). This indicates that the tetrad residues of GAV 354 
nsp16 require both proper charge and steric properties for optimal MTase activity. For 355 
these assays, two RNA substrates, 5′-teriminal 68-nt capped untranslated regions 356 
(7MeGppp-5′UTR) of GAV genome (Fig.5A) and the capped oligonucleotides 357 
7MeGpppAC20 (Fig. 5B) were tested, and the results were consistent. 358 
The 2′-O-MTase activity of GAV nsp16 mutants were also tested by nuclease P1 359 
treatment and TLC assays. As shown in Fig. 5C, all the GAV nsp16 mutants were 360 
crippled in 2′-O-MTase activity, which was in accordance with the results of the 3H-361 
methyl-labeled assays (Fig. 5A & 5B). 362 
Taken together, we concluded that the four amino acid residues (Lys-39, Asp-114, Lys-363 
144 and Glu-178) of GAV nsp16 may function as the K-D-K-E catalytic tetrad essential 364 
for 2′-O-MTase activity. 365 
Effects of MTase inhibitors on GAV nsp16 2′-O-MTase activity 366 
As viral 2′-O-MTases have been regarded as potential targets for the antiviral therapy 367 
(Kimura et al., 2013; Menachery et al., 2014), we tested whether the activity of GAV 368 
nsp16 could be inhibited by the previously characterized MTase inhibitors, such as S-369 
(5′-adenosyl)-L homocysteine (SAH), sinefungin and ribavirin. SAH is the by-product 370 
of SAM-dependent methyl transfer reaction. Sinefungin is a SAM analogue and 371 
ribavirin is a GTP analogue. All of these three small molecular compounds were often 372 
used to inhibit SAM-dependent methyltransferases (Pugh & Borchardt, 1982; Pugh et 373 
al., 1978; Selisko et al., 2010). As shown in Figure 6, sinefungin and AdoHcy had 374 
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relatively more efficient inhibition, and their half maximal inhibitory concentration 375 
(IC50) were determined as 28.7 and 73.9 μM, respectively (Fig. 6A and 6C), whereas 376 
ribavirin was less efficient on GAV nsp16 in our system (Fig. 6B). In comparison with 377 
the inhibition on other viral 2′-O-MTases, we found that these three compounds have 378 
varying effects on different MTases. For examples, the IC50 value of AdoHcy is 0.34 379 
μM for the 2′-O-MTase of Dengue virus NS5MTaseDV (Selisko et al., 2010) and 144 380 
μM for FCoV nsp16 (Decroly et al., 2008), respectively. Ribavirin did not exert 381 
significantly inhibitory effect on 2′-O-MTase of Dengue virus NS5MTaseDV (Selisko et 382 
al., 2010), similarly to our observation with GAV nsp16. 383 
 384 
Discussion 385 
Nidoviruses have linear, single-stranded RNA genomes of positive polarity that contain 386 
a 5′ cap structure and a 3′ poly(A) tail (Gorbalenya et al., 2006). Several enzymes are 387 
involved in the formation of RNA 5′ cap, including RNA triphosphatase, 388 
guanylyltransferase, guanine-N7-methyltransferase (N7 MTase) and ribose 2′-O 389 
methyltransferase (2′-O MTase) (Bouvet et al., 2012; Decroly et al., 2012; Ghosh & 390 
Lima, 2010). In coronaviruses, N-7 MTase and 2′-O MTase have been well studied, 391 
and these two methyltransferases play important roles in the modification of the viral 392 
cap structure (Chen et al., 2009; Chen et al., 2011; Decroly et al., 2011). However, little 393 
is known about the MTases of any other nidoviruses. Although bioinformatic analyses 394 
have predicted that roniviruses and toroviruses may encode a methyltransferase at the 395 
C-terminal end of ORF1ab in similarity with that of coronaviruses (Gorbalenya et al., 396 
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2006), there was no experimental evidence for the predictions. In this study, we 397 
expressed and purified the putative methyltransferases of EToV (torovirus) and GAV 398 
(ronivirus) according to the bioinformatic prediction for cleavage sites, and we 399 
provided experimental evidence that GAV nsp16 possesses the 2′-O-MTase activity.  400 
However, we were surprised that the torovirus nsp16, which is more closely related to 401 
coronavirus nsp16, did not show any 2′-O-MTase activity in our test settings. The 402 
failure to detect 2′-O-MTase activity for torovirus nsp16 may reflect its intrinsic 403 
properties or the limitations of our testing systems. Torovirus nsp16 may also adopt an 404 
unknown protein cofactor that is different from that of coronavirus. 405 
Our results indicate that GAV nsp16 could discriminate N7 methylated RNA cap from 406 
non-methylated ones similarly to coronaviral 2′-O-MTase (Decroly et al., 2008), but in 407 
contrast to other viral 2′-O-MTases such as that of dengue virus and Meaban virus 408 
which are able to transfer methyl groups from AdoMet to both methylated and 409 
unmethylated RNA caps (GpppACn and 
7MeGpppACn) at the 2′-O position of the first 410 
nucleotide (Decroly et al., 2008; Mastrangelo et al., 2007; Peyrane et al., 2007; Selisko 411 
et al., 2010). GAV nsp16 can only efficiently methylate ATP-initiated RNA substrates 412 
similarly to that of SARS-CoV nsp16, while vaccinia virus VP39 is a 2′-O-MTase that 413 
works in a sequence-nonspecific manner (Hodel et al., 1998). It demonstrates that GAV 414 
nsp16 is a more specific cap-modifying enzyme in recognition of 5′-capped mRNA. 415 
Interestingly, unlike coronavirus nsp16, GAV nsp16 can function alone in the absence 416 
of any other viral protein, suggesting that GAV nsp16 does not require a protein co-417 
factor to stimulate its enzymatic activity. As shown in our previous work, SARS-CoV 418 
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nsp10, the co-factor protein to nsp16, acts as a buttress to support the pocket involved 419 
in SAM-binding and thus enhances the SAM-binding affinity (Chen et al., 2011).  420 
In modeled 3D structure, GAV nsp16 has remarkable difference to that of SARS-CoV 421 
nsp16. First, the SAM-binding pocket GAV nsp16 appears to have a more rigid structure, 422 
and may be stable enough to bind with the methyl donor SAM. In contrast, SARS-CoV 423 
nsp16 SAM-binding pocket possesses a flexible loop100-108 (Fig. 4). Second, the β3-424 
strand of SARS-CoV nsp16 is missing in GAV nsp16. Third, the surface electrostatic 425 
potential analysis shows that the RNA-binding groove of GAV nsp16 is longer than that 426 
of SARS nsp16 (Fig. 4E), the former being about 32Å in length and fitting well with 427 
the 6-nt RNA substrate (7MeGpppAC5), which is consistent with our observation that the 428 
shortest RNA substrate with which GAV nsp16 showed 2'-O-MTase activity is 6-nt long  429 
(Fig.2D). This observation may in part explain why GAV does not need a viral protein 430 
co-factor for its enzymatic activity whereas SARS-CoV nsp16 requires nsp10 to extend 431 
its RNA-binding groove for accommodating substrate RNA efficiently as demonstrated 432 
in our previous study (Chen et al., 2011). These structural differences may contribute 433 
to the distinct properties of coronavirus and ronivirus 2'-O-MTases. 434 
Through sequence alignment and mutational analysis, we identified the conserved K-435 
D-K-E catalytic tetrad of GAV nsp16, which is similar to that of the typical RNA cap-436 
1 structure capping enzymes. The catalytic tetrad is K39-D114-K144-E178 (Fig.4A). 437 
Homology modeling results show that GAV nsp16 has six-stranded β-sheet parallel 438 
arrayed in the middle of the protein surrounded by α-helices and loops, while the β-439 
sheet is seven-stranded in SARS-CoV nsp16 and many other known 2′-O-440 
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methyltransferases (Chen et al., 2011; Martin & McMillan, 2002). Nevertheless, the 441 
six-stranded β-sheet is also reported for some MTases, e.g. the RNA methyltransferase 442 
TlyA (Arenas et al., 2011), whose missing β-strand is the third one located at the edge 443 
of the seven-stranded β-sheet structure. The four amino acid residues in the catalytic 444 
tetrad K39-D114-K144-E178 of GAV nsp16 are located at similar positions compared with 445 
the tetrad K46-D130-K170-E203 of SARS-CoV nsp16.  446 
It is well-known that the cap structure is very important to mRNA stability and protein 447 
translation. It has been demonstrated that the 2′-O methylation of viral RNA cap is also 448 
important for RNA viruses to evade host innate immune recognition (Daffis et al., 2010; 449 
Garcia-Sastre, 2011; Zust et al., 2011). Therefore, viral capping enzymes may be used 450 
as potential targets for the therapeutics against viruses. Recently, we demonstrated that 451 
coronavirus nsp10-derived short peptide can potently inhibit nsp16 2′-O-MTase activity 452 
in vitro and viral replication in animals (Wang et al., 2015). In the future, small 453 
molecule inhibitors can be developed to target the 2′-O-MTases of other nidoviruses. In 454 
this study, we showed that the well-known MTase inhibitor sinefungin possessed 455 
inhibitory activity on GAV nsp16.  456 
In summary, we have identified and characterized the 2′-O-methyltransferase of GAV, 457 
extending the understanding of RNA cap formation and methylation beyond 458 
coronaviruses in the order of Nidovirales. The ronivirus 2′-O-MTase shows similar and 459 
unique features in comparison with coronavirus 2′-O-MTase. The K-D-K-E catalytic 460 
tetrad of GAV nsp16 is well conserved but ronivirus 2′-O-MTase does not require a 461 
protein co-factor for stimulating its activity and possibly possesses a six-stranded β-462 
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sheet instead of a canonical seven-stranded β-sheet in the core of the MTase structure. 463 
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Figure legends: 584 
 585 
Figure 1. Identification of nidovirus 2′-O-MTases. (A) Domain organization of the 586 
replicase pp1ab polyprotein for selected nidoviruses: SARS-CoV (coronavirus), EToV 587 
(torovirus) and GAV (ronivirus). The predicted domains are indicated, and the cleavage 588 
sites are marked with triangles. The domains include: ADRP, ADP-ribose-1′-589 
phosphatase; PLpro, papain-like proteinases; 3CLpro,  chymotrypsin-like proteinase; 590 
RdRp, RNA-dependentRNA polymerase ; Hel, helicase; ExoN, exonuclease; N7MT, 591 
N7-methyltransferase; Ne, uridylate-specific endoribonuclease (also abbreviated 592 
NendoU); 2OMT, 2′-O-methyltransferase. The coronavirus nsp10 and its similarly 593 
located counterparts in EToV and GAV are depicted in purple color, and RFS stands for 594 
the ribosomal frameshift site. (B) Expression and purification of recombinant viral 595 
proteins. The gels of SDS-PAGE were stained with Coomassie brilliant blue. Lanes 2-596 
7 are EToV nsp10, GAV nsp10, SARS nsp10, EToV nsp16, GAV nsp16 and SARS 597 
nsp16, respectively. GAV nsp10, GAV nsp16 and EToV nsp16 are GST fusion proteins, 598 
and the others are 6-histidine-tagged. (C) The activity assays of potential 2′-O 599 
methyltransferases in 3H-methyl incorporation assay. Vaccinia virus VP39 and SARS-600 
CoV nsp10/16 were used as positive control, while SARS-CoV nsp10 acted as a 601 
negative control for 2'-O-MTase activity. The CPM amounts reflect the 2′-O-MTase 602 
activity which was detected by liquid scintillation. 603 
 604 
Figure 2. RNA substrate specificity of GAV nsp16 2'-O-MTase. (A) The first 68 605 
nucleotides of the GAV genome was capped to form 7MeG*pppA-RNA, incubated with 606 
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GAV nsp16, digested to release cap structures, and analyzed by TLC. (B) SAM-607 
dependent methyltransferase activity of GAV nsp16 and SARS nsp16. Equal amounts 608 
of proteins were incubated with AC20 (white), GpppAC20 (gray) and 
7MeGpppAC20 609 
(black) in the presence of 3H-labeled SAM for 1 h, and radioactive incorporation was 610 
detected by liquid scintillation. (C) MTase activity of GAV nsp16 for capped RNAs 611 
with different initiating nucleotide. 7MeGpppAC20, 
7MeGpppCC20, 
7MeGpppUC20, 612 
7MeGpppGC20 and 
7MeGpppA were used as substrates to test GAV nsp16 activity. (D) 613 
GAV nsp16 2′-O-MTase activity on capped RNA substrates of different length. The 614 
activity was formulated as percentage (100% corresponds to that of 7MeGpppAC20). 615 
 616 
Figure 3. The optimal reaction conditions of GAV nsp16. The GAV nsp16 activity was 617 
measured in the presence of 3H-labeled SAM by counting transferred 3H-methyl. (A) 618 
Effect of temperature on the enzymatic activity. Reactions were performed in Tris buffer 619 
(pH8.0) and incubated at various temperatures. RNAs were purified by Sephadex A-50 620 
and detected by liquid scintillation. (B) Enzymatic activity of GAV nsp16 at different 621 
pH values, including citric acid-NaOH (pH6.0), Tris-HCl buffer (pH7.0-9.0), and 622 
Na2CO3-NaOH buffer (pH10-11). 100% activity corresponds to that at pH8.0. (C) The 623 
influence of positive valence metal ions on enzymatic activity. The reactions were 624 
conducted at pH8.0 on 20°C. 625 
 626 
Figure 4. Sequence alignment and homology modeling of GAV nsp16. (A) The 627 
multiple sequence alignment of selected 2′-O-methyltransferases of nidoviruses.  (B) 628 
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Ribbon representation of GAV nsp16 model structure generated modeled on the 629 
template structure of SARS nsp10/nsp16 (PDB: 3R24) (C). SAM was added in GAV 630 
nsp16 model by superimposition of the model and the structure of SARS nsp10/nsp16 631 
(3R24). β-sheets were marked in accordance with alignment result. (D) Schematic 632 
diagrams of the topology of GAV nsp16 (modeled structure) and SARS nsp16. (E) The 633 
surface electrostatic potentials of GAV nsp16 (model) and SARS nsp16. The surface 634 
electrostatic potential diagram was generated by PyMol, and blue areas represent 635 
positive charge areas while red represents negative charge areas. 636 
 637 
Figure 5. The activity of GAV wild type nsp16 and its K-D-K-E mutants. (A) MTase 638 
activity of GAV nsp16 (WT and mutants) detected by using 7MeGpppAC20 as substrates 639 
in 3H-methyl incorporation assay. (B) MTase activity of GAV nsp16 (WT and mutants) 640 
detected by using 7MeGppp-RNA (GAV 5′UTR) as substrates in 3H-methyl 641 
incorporation assay. (C) MTase activity of GAV nsp16 (WT and mutants) analyzed by 642 
RNA digestion and TLC assays. Lane 4 represents the WT of GAV nsp16, lane 2 as a 643 
negative control and lane 3 as positive control treated with vaccinia virus VP39, and 644 
the lanes 5-12 are the mutants of GAV nsp16. 645 
 646 
Figure 6. Inhibition of GAV nsp16 2′-O-MTase activity by methyltransferase inhibitors. 647 
Increasing concentration of sinefungin (A), ribavirin (B) and AdoHcy (by-product of 648 
the reaction) (C) were added in the reaction mixtures, and the activity was measured by 649 
using 3H-methyl incorporation MTase activity assays. 650 
